AI Terminal

MODULE: AI_ANALYST

Interactive Q&A, Risk Assessment, Summarization

MODULE: DATA_EXTRACT

Excel Export, XBRL Parsing, Table Digitization

MODULE: PEER_COMP

Sector Benchmarking, Sentiment Analysis

SYSTEM ACCESS LOCKED

Authenticate / Register Log In

Elbit Imaging-M Ltd.

Capital/Financing Update • Jun 5, 2018

6760_rns_2018-06-05_7aa34c4c-95e5-4bf1-9ed1-22d3abd3b8e2.pdf

Capital/Financing Update

Open in Viewer

Opens in native device viewer

ELBIT IMAGING LTD. ANNOUNCES FULL REDEMPTION OF ITS SERIES H NOTES

Tel Aviv, Israel, June 5, 2018, Elbit Imaging Ltd. (TASE, NASDAQ: EMITF) ("Elbit" or the "Company") announced today, that on May 31, 2018 it completed the full redemption of its series H notes.

About Elbit Imaging Ltd.

Elbit Imaging Ltd. operates in the following principal fields of business: (i) Medical Industries through our indirect holdings in InSightec Ltd. and Gamida Cell Ltd.; (ii) Plots in India which are designated for sale (and which were initially designated for residential projects); (iii) Plots in Eastern Europe which are designated for sale (and which were initially designated for development of commercial centers).

For Further Information: Company Contact Ron Hadassi CEO and Chairman of the Board of Directors Tel: +972-3-608-6048 Fax: +972-3-608-6050 [email protected]